PDA

View Full Version : Boehringer Ingelheim expands European Metacam indication to guinea pigs - pharmabiz.c



News Feed
06-19-18, 10:50 pm
<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial,sans-serif"></font></td><td valign="top" class="j"><font style="font-size:85%;font-family:arial,sans-serif"><br><div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFhtpn-_vp6ZgqvyLRjS98NM9apQA&clid=c3a7d30bb8a4878e06b80cf16b898331&ei=_dwpW-iJKYSO3QG1zbCACQ&url=http://www.pharmabiz.com/NewsDetails.aspx?aid%3D109545%26sid%3D2"><b>Boehringer Ingelheim expands European Metacam indication to <b>guinea pigs</b></b></a><br><font size="-1"><b><font color="#6f6f6f">pharmabiz.com</font></b></font><br><font size="-1">Boehringer Ingelheim adds a new species to its Metacam (active ingredient: meloxicam) brand in Europe, expanding the indications of this widely used analgesic and anti-inflammatory medicine to <b>guinea pigs</b>. Following an EU marketing authorization, the&nbsp;...</font><br><font size="-1" class="p"></font><br><font class="p" size="-1"><a class="p" href="http://news.google.com/news/more?ncl=dg9zmQKIV9QAyCM&authuser=0&ned=us"><nobr><b></b></nobr></a></font></div></font></td></tr></table>

More... (http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFhtpn-_vp6ZgqvyLRjS98NM9apQA&clid=c3a7d30bb8a4878e06b80cf16b898331&ei=_dwpW-iJKYSO3QG1zbCACQ&url=http://www.pharmabiz.com/NewsDetails.aspx?aid%3D109545%26sid%3D2)